JUNB and neoplasm: Earlier studies of our group in CTCs [18] and disseminated tumor cells (DTCs) [19] from breast cancer patients identified a new pair of biomarkers, namely the C-X-C motif chemokine receptor 4 (CXCR4) and the transcription factor JUNB.